Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35137
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJenkins, Alex R-
dc.contributor.authorBurtin, Chris-
dc.contributor.authorCamp, Pat G-
dc.contributor.authorLindenauer, Peter-
dc.contributor.authorCarlin, Brian-
dc.contributor.authorAlison, Jennifer A-
dc.contributor.authorRochester, Carolyn-
dc.contributor.authorHolland, Anne E-
dc.date2024-
dc.date.accessioned2024-02-29T04:07:41Z-
dc.date.available2024-02-29T04:07:41Z-
dc.date.issued2024-02-13-
dc.identifier.citationThorax 2024-04-15; 79(5)en_US
dc.identifier.issn1468-3296-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35137-
dc.description.abstractPrevious systematic reviews have provided heterogeneous and differing estimates for the efficacy of pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease (COPD). The aim of this review was to examine the efficacy of pulmonary rehabilitation programmes initiated within 3 weeks of hospital discharge following an exacerbation of COPD. An update of a previous Cochrane review was undertaken using the Cochrane Airways Review Group Specialised Register. Searches were conducted from October 2015 to August 2023 for studies that initiated pulmonary rehabilitation within 3 weeks of hospital discharge. Studies assessing the impact of solely inpatient pulmonary rehabilitation were excluded. Forest plots were generated using a generic inverse variance random effects method. Seventeen studies were included. Posthospital discharge pulmonary rehabilitation reduced hospital re-admissions (OR 0.48, 95% CI 0.30 to 0.77, I2=67%), improved exercise capacity (6 min walk test, mean difference (MD) 57 m, 95% CI 29 to 86, I2=89%; incremental shuttle walk test, MD 43 m, 95% CI 6 to 79, I2=81%), health-related quality of life (St. George's Respiratory Questionnaire, MD -8.7 points, 95% CI -12.5 to -4.9, I2=59%; Chronic Respiratory Disease Questionnaire (CRQ)-emotion, MD 1.0 points, 95% CI 0.4 to 1.6, I2=74%; CRQ-fatigue, MD 0.9 points, 95% CI 0.1 to 1.6, I2=91%), and dyspnoea (CRQ-dyspnoea, MD 1.0 points, 95% CI 0.3 to 1.7, I2=87%; modified Medical Research Council Dyspnoea Scale, MD -0.3 points, 95% CI -0.5 to -0.1, I2=60%). Significant effects were not observed for CRQ-mastery, COPD assessment test, EuroQol-5 Dimension-5 Level and mortality. No intervention-related adverse events were reported. Pulmonary rehabilitation delivered posthospital discharge for exacerbation of COPD results in a reduction in hospital re-admissions and improvements in exercise capacity, health-related quality of life and dyspnoea in the absence of any intervention-related adverse events. CRD42023406397.en_US
dc.language.isoeng-
dc.subjectCOPD exacerbationsen_US
dc.subjectexerciseen_US
dc.subjectpulmonary rehabilitationen_US
dc.titleDo pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThoraxen_US
dc.identifier.affiliationClinical Exercise and Respiratory Physiology Laboratory, Department of Kinesiology and Physical Education, Faculty of Education, McGill University, Montreal, QC, Canada.en_US
dc.identifier.affiliationREVAL-Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.;BIOMED-Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.en_US
dc.identifier.affiliationCentre for Heart Lung Innovation, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.;Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.en_US
dc.identifier.affiliationDepartment of Healthcare Delivery and Population Sciences, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA.en_US
dc.identifier.affiliationSleep Medicine and Lung Health Consultants, Pittsburgh, Pennsylvania, USA.en_US
dc.identifier.affiliationSydney School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.;Allied Health, Sydney Local Health District, Sydney, NSW, Australia.en_US
dc.identifier.affiliationSection of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT, USA.;VA Connecticut Healthcare System, West Haven, CT, USA.en_US
dc.identifier.affiliationRespiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, VIC, Australia.;Department of Physiotherapy, Alfred Health, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationInstitute for Breathing and Sleepen_US
dc.identifier.doi10.1136/thorax-2023-220333en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-4384-2342en_US
dc.identifier.pubmedid38350731-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptPhysiotherapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Dec 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.